PCVX peer analysis
Vaxcyte (PCVX) against its competitors: price, today's move, 1-year return and market value side by side.
PCVX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ARCT Arcturus | $11.03 | -9.22% | 14.54% | $313.51M |
| EVAX Evaxion | $2.93 | -4.87% | -49.13% | – |
| GOVX GeoVax Labs | $0.17 | -9.31% | -98.80% | – |
| GSK GSK | $49.12 | -0.78% | 4.65% | $99.19B |
| IBRX ImmunityBio | $7.94 | -4.22% | 236.44% | $8.79B |
| MRNA Moderna | $220.50 | -0.55% | 683.58% | $88.52B |
| NVAX Novavax | $9.54 | -5.36% | 13.17% | $1.66B |
| PFE Pfizer | $31.01 | 1.61% | 27.67% | $173.95B |
| VALN Valneva | $5.45 | -4.55% | -40.24% | – |
| VIR Vir Biotechnology | $11.02 | -2.48% | 85.83% | $1.91B |
| PCVX Vaxcyte | $60.62 | -2.27% | 35.46% | $9.76B |
- PCVX's peers: ARCT (Arcturus), EVAX (Evaxion), GOVX (GeoVax Labs), GSK (GSK), IBRX (ImmunityBio), MRNA (Moderna), NVAX (Novavax), PFE (Pfizer).
Updated 2026-11-03 02:01 UTC